ARCHIVES

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

This article is from The Cancer Letter archive.

Vol. 01 No. 48 | November 28, 1975

Download PDF Visit The Full Archive

Related Articles

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007